AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Looking for low annual fee credit cards for travel? Explore options to save money and enhance your travel experience.
18,244 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Investors obsess over the idea of a spacex stock millionaire maker? But the truth hinges on two big factors. This gui...
Investors are weighing Microsoft’s next steps in a fast-changing tech landscape. This guide breaks down likely cataly...
Strategy Inc. escalated its Bitcoin purchases with a $1.3 billion bet funded largely by new common shares and STRC pr...
Tariff-Related Lawsuits Could Hurt Costco Stock Now examines how legal challenges tied to tariffs can affect a retail...
The White House has tapped a former private-prison executive to head ICE on an acting basis, narrowing leadership gap...
Even as policymakers warn of a large home shortage, today’s housing starts data show persistent headwinds that keep h...
Usio's Q4 2025 earnings reveal a business building momentum in payments services. This analysis breaks down the numbe...
May housing data shows a deliberate pause in starts as builders rebalance pricing and incentives, signaling a strateg...
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
A fresh rally in fintech names has traders watching carefully. This article explores why fiserv stock just popped, wh...
Investors are increasingly betting against Wall Street with inverse ETFs. This article explains how these funds work,...